Abstract:Abstract We previously showed that the transcription factor AP2B (TFAP2B) protein could specifically bind to the promoter of human telomerase reverse transcriptase (hTERT) and selectively activate hTERT in lung cancer cells but not in normal cells. The common 5p15.33 and 6p21.33 chromosomal variants that harbor the hTERT and TFAP2B genes, have been identified as susceptibility loci for lung cancer and show a significant autosomal copy number gain in lung adenocarcinoma. We tested the hypothesis that amplification of the TFAP2B gene and up-regulation of its gene products can transform lung cells and promote tumorigenesis. We first analyzed levels of TFAP2B gene expression in human lung cancer cell lines, small-airway epithelial cells (SAECs),primary normal HBEC and in immortalized or transformed HBECs by gene expression profiling on gene microarrays. Levels of TFAP2B gene expression varied significantly between different cell lines but on average were greater than those of primary normal HBECs and SAECs. A linkage distance cluster analysis of the TFAP2B pathway-associated genes showed a significant classification of lung cancer cell types, distinguishing tumor cells from normal ones. Differential expression of the TFAP2B gene in normal lung and cancer cells was confirmed by qRT-PCR. We analyzed copy number variations (CNVs) specifically linked to hTERT and TFAP2B loci by mining the published genome-wide SNP data set from 370 NSCLC tumor samples and confirmed a significant copy number gain for both hTERT and TFAP2B with average copy numbers of 4.5 and 3.5, respectively. We performed immunohistochemical (IHC) analysis of TFAP2B protein expression in 30 paired human lung tumors and normal lung tissues that are immediately (<1.0 cm) adjacent or distal (2-3 cm) to the tumor sites. Significantly up-regulated TFAP2B protein expression was detected in almost all the adenocarcinomas and squamous carcinomas and significantly reduced expression was observed in the immediately adjacent normal lung and HBECs and the distal normal lung and HBECs. The differential TGFAP2B protein expression patterns shown by the IHC analysis were confirmed by Western blot analysis. We performed immuno-fluorescence imaging analysis of the endogenous TFAP2B expression and detected distinctive subcellular and nuclear localization in normal HBECs compared to tumor cells. Ectopic activation of TFAP2B by wt-TFAP2B gene transfer significantly altered the cellular and nuclear compartmentalization and architecture. Activation of TFAP2B in stable clones of normal HBECs induced clonogenecity of these cells compared to the parent cells. Our results suggest an important role of TFAP2B in lung cancer carcinogenesis and potential translational applications using TFAP2B as a novel biomarker for lung cancer and as a therapeutic target. (Supported by NIH SPORE P50CA70907 and RO1CA116322 grants) Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3921.

Abstract 3921: Amplification of the TFAP2B Gene and Upregulation of Its Gene Products Promote Human Bronchial Epithelial Cell (HBEC) Transformation and Carcinogenesis

TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling

Tumor-specific Activation of Human Telomerase Reverses Transcriptase Promoter Activity by Activating Enhancer-binding Protein-2β in Human Lung Cancer Cells

Abstract 5647: Investigating the role of AP-2α in melanomagenesis

TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation

TFAP2A Promotes Cervical Cancer Via a Positive Feedback Pathway with PD‑L1.

TFAP2A Induced KRT16 as an Oncogene in Lung Adenocarcinoma via EMT.

Expression Of Telomeric Repeat Binding Factor 1 Protein In Nonsmall Cell Lung Cancer With Human Telomerase Reverse Transcriptase Positive

Abstract 1793: Transmembrane serine protease TMPRSS11B promotes tumorigenesis in lung squamous cell carcinoma through enhanced lactate export and modulation of the tumor microenvironment

The Oncogenic Role of TFAP2A in Bladder Urothelial Carcinoma Via a Novel Long Noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 Axis.

TCF19 Promotes Cell Proliferation and Tumor Formation in Lung Cancer by Activating the Raf/MEK/ERK Signaling Pathway

Abstract 3685: Targeting a novel cell surface serine protease TMPRSS11B for lung cancer therapy

Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma

TFAP2A-activated ITGB4 Promotes Lung Adenocarcinoma Progression and Inhibits CD4+/CD8++ /Cd8+t-Cell Infiltrations by Targeting NF-κB Κ B Signaling Pathway

Abstract 1132: Oncogenic role of EAPII/TTRAP in lung cancer development and its activation of MAPK-ERK pathway

Human Transcription Factor TFAP2γ Promotes Breast Cancer Cell Proliferation

Activating Transcription Factor 2 Expression Mediates Cell Proliferation and is Associated with Poor Prognosis in Human Non-Small Cell Lung Carcinoma.

Abstract 634: Tuba-seq and CRISPR/Cas9 analysis of TBX2 subfamily genes: Exploring contextual tumor suppression in lung adenocarcinoma

TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway.

Defective Expression Of Transforming Growth Factor Beta Receptor Type Ii Is Associated With Cpg Methylated Promoter In Primary Non-Small Cell Lung Cancer

Abstract #5347: the Lung Tumor Suppressor GPRC5A Inhibits Activation of NF-\#954;B in Human Non-Small Cell Lung Adenocarcinoma Cells